SCHEMBL29375481

SCHEMBL29375481

NC(=S)NNCc1cc(F)ccc1Br

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSL P07711 4/20 0.34
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
PLEC Q15149 1/20 0.33
NTRK1 P04629 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MAOB P27338 1/20 0.32
GAA P10253 1/20 0.32
PLA2G1B P04054 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32
MAPK8 P45983 1/20 0.32
LMNA P02545 1/20 0.31
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21984701 0.78 GAA (0.39) ALDH1A1POLBSMN1; SMN2MAOBGAA
SCHEMBL29372134 0.75 GAA (0.45) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL2025930 0.75 GAA (0.45) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL30712797 0.72 NTRK1 (0.33) MEN1ALDH1A1MAPTKMT2APOLB
SCHEMBL2025928 0.71 MAPT (0.34) MEN1MAPTKMT2AGAADPP4
SCHEMBL28471761 0.71 EGFR (0.34) CTSLMEN1ALDH1A1MAPTKMT2A
SCHEMBL18588938 0.71 SLC6A4 (0.50) MEN1ALDH1A1MAPTKMT2APOLB
SCHEMBL28269593 0.70 ALDH1A1 (0.47) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL29263986 0.70 NTRK1 (0.35) MEN1ALDH1A1MAPTKMT2APOLB
SCHEMBL7797904 0.70 PLA2G1B (0.44) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115246817-B Crystal form beta of compound A benzoate, preparation method thereof and pharmaceutical composition containing crystal form beta 深圳信立泰药业股份有限公司 2024-06-18 CN disclosed
CN-113493435-B Amorphous compound A benzoate, preparation method thereof and pharmaceutical composition containing amorphous compound A benzoate 深圳信立泰药业股份有限公司 2024-01-26 CN disclosed
CN-115246817-A Crystal form beta of compound A benzoate, preparation method thereof and pharmaceutical composition containing crystal form 深圳信立泰药业股份有限公司 2022-10-28 CN disclosed
CN-106349215-B Amorphous form of compound A benzoate, preparation method thereof and pharmaceutical composition containing amorphous form 深圳信立泰药业股份有限公司 2022-02-08 CN disclosed